Aurora Financial Journal

Dr. Reddy's Laboratories Ltd (RDY)

NYSE · Health care · Pharmaceutical Preparations · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended March 31, 2025), Dr. Reddy's Laboratories Ltd reported revenue of ₹325.54B and net income of ₹56.54B. Annual financial statements are available for fiscal years 2016 to 2025, taken from the company's filings with the SEC.

Open interactive financials →

Key financials

INRFY2025
2025-03-31		FY2024
2024-03-31		FY2023
2023-03-31		FY2022
2022-03-31		FY2021
2021-03-31
Income statement
Revenue₹325.54B₹279.16B₹245.88B₹214.39B₹189.72B
Gross profit₹190.43B₹163.61B₹139.34B₹113.84B₹103.08B
Operating income₹71.84B₹67.73B₹57.14B₹29.48B₹24.28B
Net income₹56.54B₹55.68B₹45.07B₹23.57B₹17.24B
Diluted EPS₹67.78₹66.80₹54.17₹28.34₹20.73
Cash flow
Operating cash flow₹46.43B₹45.43B₹58.88B₹28.11B₹35.70B
Capital expenditure₹27.50B₹16.40B₹11.32B₹14.66B₹9.74B
Free cash flow₹18.92B₹29.03B₹47.55B₹13.45B₹25.96B
Balance sheet
Cash and equivalents₹14.65B₹7.11B₹5.78B₹14.85B₹14.83B
Total assets₹492.99B₹387.52B₹321.85B₹292.83B₹265.49B
Total liabilities₹155.82B₹106.97B₹90.86B₹102.30B₹92.43B
Total debt₹8.72B₹7.30B₹6.08B₹6.76B₹7.16B
Shareholders' equity₹333.39B₹280.55B₹230.99B₹190.53B₹173.06B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in INR as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full RDY page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open RDY financials →